Monopril

Monopril is a brand name of fosinopril, approved by the FDA in the following formulation(s):

MONOPRIL (fosinopril sodium - tablet; oral)

• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: May 16, 1991
  
  Strength(s): 10MG ^[AB], 20MG ^[AB]


• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: March 28, 1995
  
  Strength(s): 40MG ^[RLD][AB]

Has a generic version of Monopril been approved?

Yes. The following products are equivalent to Monopril:

fosinopril sodium tablet; oral

• 
  Manufacturer: APOTEX INC
  
  Approval date: May 17, 2005
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA LTD
  
  Approval date: March 30, 2011
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: INVAGEN PHARMS
  
  Approval date: April 20, 2005
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: April 23, 2004
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: April 23, 2004
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: November 25, 2003
  
  Strength(s): 10MG ^[AB], 20MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: December 23, 2004
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: August 31, 2006
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]


• 
  Manufacturer: WATSON LABS FLORIDA
  
  Approval date: October 15, 2004
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 40MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Monopril. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Monopril.

See also...

• Monopril Consumer Information (Drugs.com)
• Monopril Consumer Information (Wolters Kluwer)
• Monopril Consumer Information (Cerner Multum)
• Monopril Advanced Consumer Information (Micromedex)
• Monopril AHFS DI Monographs (ASHP)
• Fosinopril Consumer Information (Wolters Kluwer)
• Fosinopril Consumer Information (Cerner Multum)
• Fosinopril Advanced Consumer Information (Micromedex)
• Fosinopril Sodium AHFS DI Monographs (ASHP)

Norgesic

See also: Generic Norgesic Forte

Norgesic is a brand name of aspirin/caffeine/orphenadrine, approved by the FDA in the following formulation(s):

NORGESIC (aspirin; caffeine; orphenadrine citrate - tablet; oral)

• 
  Manufacturer: MEDICIS
  
  Approval date: October 27, 1982
  
  Strength(s): 385MG;30MG;25MG ^[AB]

Has a generic version of Norgesic been approved?

Yes. The following products are equivalent to Norgesic:

INVAGESIC (aspirin; caffeine; orphenadrine citrate tablet; oral)

• 
  Manufacturer: SANDOZ
  
  Approval date: November 27, 1996
  
  Strength(s): 385MG;30MG;25MG ^[AB]

ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE (aspirin; caffeine; orphenadrine citrate tablet; oral)

• 
  Manufacturer: SANDOZ
  
  Approval date: December 31, 1996
  
  Strength(s): 385MG;30MG;25MG ^[AB]


• 
  Manufacturer: STEVENS J
  
  Approval date: April 30, 1999
  
  Strength(s): 385MG;30MG;25MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Norgesic. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Norgesic.

See also...

• Norgesic Consumer Information (Cerner Multum)
• Norgesic Advanced Consumer Information (Micromedex)
• Orphenadrine/Aspirin/Caffeine Consumer Information (Wolters Kluwer)
• Aspirin/caffeine/orphenadrine Consumer Information (Cerner Multum)
• Orphenadrine w/A.C. Advanced Consumer Information (Micromedex)
• Orphenadrine, aspirin, and caffeine Advanced Consumer Information (Micromedex)

Tolmin

Tolmin may be available in the countries listed below.

Ingredient matches for Tolmin

Mianserin

Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Tolmin in the following countries:

• Denmark

International Drug Name Search

Prozac Weekly

See also: Generic Prozac

Prozac Weekly is a brand name of fluoxetine, approved by the FDA in the following formulation(s):

PROZAC WEEKLY (fluoxetine hydrochloride - capsule, delayed rel pellets; oral)

• 
  Manufacturer: LILLY
  
  Approval date: February 26, 2001
  
  Strength(s): EQ 90MG BASE ^[RLD][AB]

Has a generic version of Prozac Weekly been approved?

A generic version of Prozac Weekly has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Prozac Weekly and have been approved by the FDA:

fluoxetine hydrochloride capsule, delayed rel pellets; oral

• 
  Manufacturer: BARR
  
  Approval date: March 24, 2010
  
  Strength(s): EQ 90MG BASE ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: March 22, 2010
  
  Strength(s): EQ 90MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prozac Weekly. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Fluoxetine enteric pellets and methods for their preparation and use
  Patent 5,910,319
  Issued: June 8, 1999
  Inventor(s): Anderson; Neil R. & Harrison; Roger G. & Lynch; Daniel F. & Oren; Peter L.
  Assignee(s): Eli Lilly and Company
  A superior enteric formulation of the antidepressant drug, fluoxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
  
  Patent expiration dates:
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION
  
  



• 
  Method for the treatment of CNS disorders
  Patent 5,985,322
  Issued: November 16, 1999
  Inventor(s): Anderson; Neil R. & Harrison; Roger F. & Lynch; Daniel F. & Oren; Peter L.
  Assignee(s): Eli Lilly and Company
  An improved method for the treatment of central nervous system disorders comprises treating patients with an enteric fluoxetine formulation.
  
  Patent expiration dates:
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA
  
  



• 
  Fluoxetine enteric pellets and methods for their preparation and use
  Patent RE39030
  Issued: March 21, 2006
  Inventor(s): Anderson; Neil Robert & Harrison; Roger Garrick & Lynch; Daniel Frederick & Oren; Peter Lloyd
  Assignee(s): Eli Lilly and Company
  A superior enteric formulation of the antidepressant drug, fluoxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
  
  Patent expiration dates:
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION
    ✓ 
    Drug product
  
  
  
  • May 29, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA
    ✓ 
    Drug product
  
  

See also...

• Prozac Weekly Delayed-Release Capsules Consumer Information (Wolters Kluwer)
• Prozac Weekly Consumer Information (Cerner Multum)
• Prozac Weekly Advanced Consumer Information (Micromedex)
• Fluoxetine Consumer Information (Drugs.com)
• Fluoxetine Consumer Information (Wolters Kluwer)
• Fluoxetine Delayed-Release Capsules Consumer Information (Wolters Kluwer)
• Fluoxetine Solution Consumer Information (Wolters Kluwer)
• Fluoxetine Consumer Information (Cerner Multum)
• Alti-Fluoxetine Hydrochloride Advanced Consumer Information (Micromedex)
• Phl-Fluoxetine Advanced Consumer Information (Micromedex)
• Fluoxetine Advanced Consumer Information (Micromedex)
• Fluoxetine Hydrochloride AHFS DI Monographs (ASHP)

Ophthaine

See also: Generic Ophthetic

Ophthaine is a brand name of proparacaine ophthalmic, approved by the FDA in the following formulation(s):

OPHTHAINE (proparacaine hydrochloride - solution/drops; ophthalmic)

• 
  Manufacturer: APOTHECON
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.5% ^[RLD][AT]

Has a generic version of Ophthaine been approved?

Yes. The following products are equivalent to Ophthaine:

ALCAINE (proparacaine hydrochloride solution/drops; ophthalmic)

• 
  Manufacturer: ALCON
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.5% ^[AT]

proparacaine hydrochloride solution/drops; ophthalmic

• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: September 29, 1995
  
  Strength(s): 0.5% ^[AT]


• 
  Manufacturer: TAYLOR PHARMA
  
  Approval date: March 16, 2000
  
  Strength(s): 0.5% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ophthaine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ophthaine.

See also...

• Proparacaine Drops Consumer Information (Wolters Kluwer)
• Proparacaine Ophthalmic Advanced Consumer Information (Micromedex)

Melodyn

Melodyn may be available in the countries listed below.

Ingredient matches for Melodyn

Meloxicam

Meloxicam is reported as an ingredient of Melodyn in the following countries:

• Hungary


• Slovakia

International Drug Name Search

Papaverin Hydrochloric

Papaverin Hydrochloric may be available in the countries listed below.

Ingredient matches for Papaverin Hydrochloric

Papaverine

Papaverine hydrochloride (a derivative of Papaverine) is reported as an ingredient of Papaverin Hydrochloric in the following countries:

• Georgia

International Drug Name Search

Coagulation Factor XIII, Human

ATC (Anatomical Therapeutic Chemical Classification)

B02BD07

CAS registry number (Chemical Abstracts Service)

0009013-56-3

Therapeutic Categories

Hemostatic agent

Blood coagulation factor substitute

Foreign Names

• Factor XIII coagulationis sanguinis humanus (Latin)
• Blutgerinnungsfaktor XIII vom Menschen (German)
• Facteur XIII de coagulation humain (French)

Generic Names

• Fibrinase (IS)
• Fibrin-stabilizing factor (IS: FSF)
• FSF (IS)
• Laki-Lorand factor (IS: LLF)
• LLF (IS)

Brand Names

• Beriplast P
  CSL Behring, Japan



• Beriplast
  CSL Behring, Japan



• Bolheal
  Chemo-Sero-Therapeutic Research InstitutKaketsuken, Japan



• Fibrogammin
  Aventis Behring, Israel; CSL Behring, Germany; ZLB Behring, Belgium



• Fibrogammin P
  Aventis, Argentina; Aventis Behring, Israel; CSL Behring, Austria; CSL Behring, Switzerland; CSL Behring, United Kingdom; CSL Behring, Japan; CSL Behring, Luxembourg; ZLB Behring, Hong Kong



• Tisseel (Coagulation Factor XIII, Human and Fibrinogen)
  Baxter, Austria

International Drug Name Search

Glossary

IS	Inofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Ansi

Ansi may be available in the countries listed below.

Ingredient matches for Ansi

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Ansi in the following countries:

• Indonesia

International Drug Name Search

Amoxicilline Zydus

Amoxicilline Zydus may be available in the countries listed below.

Ingredient matches for Amoxicilline Zydus

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline Zydus in the following countries:

• France

International Drug Name Search

Erisol

Erisol may be available in the countries listed below.

Ingredient matches for Erisol

Erythromycin

Erythromycin is reported as an ingredient of Erisol in the following countries:

• Argentina

International Drug Name Search